ABIVAX Socit Valuation
| AAVXF Stock | USD 12.36 0.00 0.00% |
Do you want to know what the current value of ABIVAX Socit Anonyme is today? Calculating the true value of any business or its net worth is not as easy as it may seem. While the market cap of a public entity, such as ABIVAX Socit, is its stock price multiplied by the total number of shares outstanding, calculating ABIVAX Socit's enterprise value requires a different approach. It uses ABIVAX Socit's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
ABIVAX Socit Anonyme shows a prevailing Real Value of $14.26 per share. The current price of the entity is $12.36. At this time, the entity appears to be undervalued. Our model approximates the value of ABIVAX Socit Anonyme from evaluating the entity fundamentals such as Operating Margin of 4.66 %, shares owned by insiders of 4.67 %, and Shares Outstanding of 22.3 M as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we favor locking in undervalued instruments and disposing overvalued instruments since, at some future date, asset prices and their ongoing real values will blend. ABIVAX Socit Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as ABIVAX Socit's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today
Please note that ABIVAX Socit's price fluctuation is somewhat reliable at this time. Calculation of the real value of ABIVAX Socit Anonyme is based on 3 months time horizon. Increasing ABIVAX Socit's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ABIVAX Socit Anonyme is useful when determining the fair value of the ABIVAX pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of ABIVAX Socit. Since ABIVAX Socit is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ABIVAX Pink Sheet. However, ABIVAX Socit's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Estimating the potential upside or downside of ABIVAX Socit Anonyme helps investors to forecast how ABIVAX pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ABIVAX Socit more accurately as focusing exclusively on ABIVAX Socit's fundamentals will not take into account other important factors: ABIVAX Socit Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining ABIVAX Socit's current stock value. Our valuation model uses many indicators to compare ABIVAX Socit value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABIVAX Socit competition to find correlations between indicators driving ABIVAX Socit's intrinsic value. More Info.ABIVAX Socit Anonyme is number one stock in price to sales category among related companies. It is number one stock in price to earning category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value ABIVAX Socit by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ABIVAX Socit's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABIVAX Socit's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ABIVAX Socit's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ABIVAX Socit and how it compares across the competition.
About ABIVAX Socit Valuation
The pink sheet valuation mechanism determines the current worth of ABIVAX Socit Anonyme on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ABIVAX Socit Anonyme. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ABIVAX Socit Anonyme based exclusively on its fundamental and basic technical indicators. By analyzing ABIVAX Socit's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ABIVAX Socit's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ABIVAX Socit. We calculate exposure to ABIVAX Socit's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ABIVAX Socit's related companies.ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.
8 Steps to conduct ABIVAX Socit's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ABIVAX Socit's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ABIVAX Socit's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ABIVAX Socit's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ABIVAX Socit's revenue streams: Identify ABIVAX Socit's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ABIVAX Socit's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ABIVAX Socit's growth potential: Evaluate ABIVAX Socit's management, business model, and growth potential.
- Determine ABIVAX Socit's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ABIVAX Socit's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
ABIVAX Socit Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as ABIVAX Socit does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 16.8 M | |
| Retained Earnings | -78.9 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABIVAX Socit Anonyme. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in commodities. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fund Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |